Corporate Symposia
SUNDAY 24 SEPTEMBER
VALUE OF IMMUNOGLOBULINS IN THE MANAGEMENT OF INFECTIOUS DISEASES AND DONOR SPECIFIC ANTIBODIES - Organized by Biotest
Please click here for the programme
Room no. 114 / Sunday 24th September, 2017 / 13:00 – 14:30
Chair: Florian Wagner, Hamburg (Germany)
- Strategies for prevention of CMV disease in thoracic patients
Florian Wagner, Hamburg, Germany - Successful treatment of early DSA after lung transplantation with IgM-enriched human intravenous immunoglobulins
Fabio Ius, Hannover, Germany - Prevention of HBV recurrence in liver Tx patients with HBIGs
Frederik Nevens, Leuven, Belgium
* * * * * * * * * * * * * * * * * * * * * * * * *
Luncheon Symposium - Organized by Immucor
Please click here for the programme
Room no. 118/119 / Sunday 24th September, 2017 / 13:00 – 14:30
- “Procare, a Dutch multicentric study to determine the clinical relevance of pre-transplant DSA”
F. H. J. Claas, Immunogenetics & Transplantation - LUMC, The Netherlands - “Latest developments in renal post-transplant monitoring”
Michael Spigarelli, VP Medical Affairs, Immucor
* * * * * * * * * * * * * * * * * * * * * * * * *
MONDAY 25 SEPTEMBER
DIFFERENT PATIENTS, DIFFERENT NEEDS. CAN WE DO MORE? - Organized by Chiesi
Please click here for the programme
Room no. 115 / Monday 25th September , 2017 / 13:00 – 14:00
Chair: Julio Pascual - Spain
- Patients with “recognised” sensitivity to tacrolimus pharmacokinetics: risk factors and implications for treatment
Lucrezia Furian, Padua (Italy) - Patients with “hidden” sensitivity to tacrolimus pharmacokinetics: identification and management
Klemens Budde, Berlin (Germany)
* * * * * * * * * * * * * * * * * * * * * * * * *
Please click here for the programme
Room no. 116 / Monday 25th September, 2017 / 13:00 – 14:30
Moderator: John J. Friedewald, MD - Northwestern University Feinberg School of Medicine
Presenters:
- Philip F. Halloran MD, Ph.D - Alberta Transplant Applied Genomics Centre
- Georg Bohmig, MD - Medical University of Vienna
- Carmen Lefaucheur, MD, Ph.D - Paris Transplant Group
- Luciano Potena, MD, Ph.D - University of Bologna
- Andreas Zuckermann, MD - Medical University of Vienna
- Antoine Roux, MD, PhD. - Foch Hospital of Paris
* * * * * * * * * * * * * * * * * * * * * * * * *
IMMUNOSUPPRESSIVE DRUG MONITORING: THE RIGHT DOSE FOR EACH PATIENT - Organized by Sandoz
Please click here for the programme
Room no. 117 / Monday September 25th, 2017 / 13:00 - 14:00
Chair: Pierre MARQUET, Limoges, France
Marta CRESPO BARRIO, Barcelona, Spain
- Technical innovations and perspectives in therapeutic drug monitoring
Pierre MARQUET, Limoges, France - Immunosuppressive drug monitoring: a transplant physician’s point-of-view
Frederick NEVENS, Leuven, Belgium - Immunosuppressive drug monitoring: a transplanted patient’s perspective
Hakan HEDMAN, Sweden - Discussion + Q&A session
* * * * * * * * * * * * * * * * * * * * * * * * *
TUESDAY 26 SEPTEMBER
TRANSFORMING TRANSPLANTATION - Organized by Novartis
Please click here for the programme
Room no. 111/112 Tuesday, 26th September, 2017 / 13:00 - 14:00
Current challenges and future perspectives in renal transplantation
- An introduction to current challenges and future perspectives in renal transplantation - The TRANSFORM Study
Chair: Julio Pascual (Spain) - Perspectives on patient populations - Living Donors
Stefan Berger (The Netherlands) - How could emerging clinical evidence impact daily treatment options?
Claudia Sommerer (Germany)
* * * * * * * * * * * * * * * * * * * * * * * * *
Room no. 115 / Tuesday 26th September, 2017 / 17:00 – 18:30
- Welcome and Introductions
Nassim Kamar - AMR: Transplant Glomerulopathy and Emerging Therapies
Robert A. Montgomery - CMV: Overcoming Therapeutic Limitations with Emerging Therapies
Camille Nelson Kotton - Interactive Panel Discussion (Clinical Cases and Current Issues in AMR and CMV Management)
All faculty - Audience Q&A and Discussion
All faculty
* * * * * * * * * * * * * * * * * * * * * * * * *
